Factors Contributing to the Use of Intensity Modulated Versus 3D Conformal Radiation Therapy for Stage III Non-Small Cell Lung Cancer: A SEER-Medicare Study

被引：1
|
作者：
Harris, J. P. [1 ]
Loo, B. W. [1 ]
Diehn, M. [1 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷
关键词：
D O I：
10.1016/j.ijrobp.2014.05.1746
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2938
引用
收藏
页码：S580 / S580
页数：1
相关论文
共 50 条
  • [31] Retrospective Analysis of Omitting Clinical Target Volume for Stage III Non-Small Cell Lung Cancer Treated With Intensity Modulated Radiation Therapy
    Zhu, G.
    Liang, X.
    Yu, R.
    Shi, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E415 - E415
  • [32] 3D conformal radiotherapy in resected non-small cell lung cancer
    Tiefenbacher, U
    Eble, MJ
    Bischoff, H
    Oetzel, D
    Manegold, C
    Wannenmacher, M
    RADIOLOGY, 2000, 217 : 407 - 408
  • [33] Disparities in Access to Multidisciplinary Cancer Consultations and Treatment for Patients With Early-Stage Non-Small Cell Lung Cancer: A SEER-Medicare Analysis
    Liu, You-Chi
    Schmidt, Rachel O.
    Kapadia, Nirav S.
    Phillips, Joseph D.
    Moen, Erika L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (01): : 102 - 110
  • [34] Intensity-modulated radiation therapy in non-small cell lung cancers
    Ayadi, M.
    Zahra, N.
    Thariat, J.
    Bouilhol, G.
    Boissard, P.
    Van Houtte, P.
    Claude, L.
    Mornex, F.
    CANCER RADIOTHERAPIE, 2014, 18 (5-6): : 406 - 413
  • [35] Patient and county level determinants of surgical treatment for non-small cell lung cancer: A SEER-Medicare analysis
    Odahowski, Cassie Lewis
    Alberg, Anthony J.
    Schootman, Mario
    Zhang, Jiajia
    Eberth, Jan M.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (01)
  • [36] Comparative Long-term Morbidity of Intensity Modulated vs. Conformal Radiation Therapy (RT) for Prostate Cancer: A SEER-Medicare Analysis
    Sheets, N.
    Goldin, G. H.
    Meyer, A. M.
    Darter, J. D.
    Wu, Y.
    Holmes, J. A.
    Reeve, B. B.
    Godley, P. A.
    Carpenter, W. R.
    Chen, R. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S43 - S43
  • [37] Intensity-modulated radiation therapy versus volumetric-modulated arc therapy in non-small cell lung cancer: assessing the risk of radiation pneumonitis
    Rosas, Sara
    Barbosa, Barbara
    Couto, Jose G.
    JOURNAL OF RADIOTHERAPY IN PRACTICE, 2018, 17 (01) : 6 - 11
  • [38] Factors associated with the use of immune checkpoint inhibitors in adults with metastatic non-small cell lung cancer and pre-existing autoimmune disease: A SEER-Medicare study
    Gohil, Shrey
    Chen, Hua
    Lewis, Whitney E.
    Trivedi, Meghana
    Aparasu, Rajender R.
    Johnson, Michael L.
    JOURNAL OF GERIATRIC ONCOLOGY, 2024, 15 (08)
  • [39] Comparison of 3-D Conformal and Intensity Modulated Radiation Therapy Outcomes for Locally Advanced Non-Small Cell Lung Cancer in NRG Oncology/RTOG 0617
    Chun, S. G.
    Hu, C.
    Choy, H.
    Komaki, R. U.
    Timmerman, R. D.
    Schild, S. E.
    Bogart, J. A.
    Dobelbower, M. C.
    Bosch, W. R.
    Galvin, J. M.
    Kavadi, V. S.
    Narayan, S.
    Iyengar, P.
    Robinson, C. G.
    Wynn, R.
    Raben, A.
    Augspurger, M.
    MacRae, R. M.
    Paulus, R.
    Bradley, J. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S1 - S2
  • [40] Isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC) - a feasibility study
    Haslett, K.
    Ashcroft, L.
    Bayman, N.
    Franks, K.
    Groom, N.
    Hannah, G.
    Harden, S.
    Harris, C.
    Harrow, S.
    Hatton, M.
    McCloskey, P.
    McDonald, F.
    Ryder, W. D. J.
    Faivre-Finn, C.
    LUNG CANCER, 2018, 115 : S62 - S63
12345